Eculizumab for the Treatment of an Atypical Hemolytic Uremic Syndrome with Mutations in Complement Factor I and C3
AuthID
P-00K-7YM
P-00K-7YM
© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service